Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alliance Pharma delays preliminary results

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday. The AIM-traded firm said the results, initially scheduled for 23 April, would now be delayed until early May.

It said it expected to provide an update on the publication date by 26 April.

Following an earlier announcement on 5 April, Alliance Pharma informed shareholders that despite the advanced stage of the audit process, its auditor, Deloitte LLP, had requested more time to finalise their work.

"Alliance reiterates that the details provided in the full year trading update on 29 January remain accurate," the board said in its statement.

At 1414 BST, shares in Alliance Pharma were down 1.63% at 36.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Hvivo scores £2.5m contract for Omicron characterisation study
(Sharecast News) - Contract research organisation Hvivo has secured a £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicron characterisation study after the manufacture of its Omicron BA.5 challenge agent was successfully completed in 2023.
MP Evans purchases minority stakes in Indonesian subsidiaries
(Sharecast News) - Palm oil producer MP Evans has purchased a 5% minority holding in the majority of its Indonesian subsidiary trading companies.
JPMorgan upgrades St James's Place, Quilter to 'overweight'
(Sharecast News) - JPMorgan Cazenove upgraded St James's Place and Quilter to 'overweight' from 'neutral' on Monday as it took a look at UK wealth managers.
Shein eyeing potential London listing
(Sharecast News) - Fast fashion retailer Shein will file paperwork for a potential floatation on the London Stock Exchange as soon as this week, according to Sky News, with an initial public offering potentially valuing the firm at roughly £51.7bn.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.